Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
Clinical trial NCT03143101 · COMPLETED
Trial details
- NCT number
- NCT03143101
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2017-09-29
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.